Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does FENOFIBRATE Cause Multiple organ dysfunction syndrome? 59 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 59 reports of Multiple organ dysfunction syndrome have been filed in association with FENOFIBRATE (Fenofibrate). This represents 1.0% of all adverse event reports for FENOFIBRATE.

59
Reports of Multiple organ dysfunction syndrome with FENOFIBRATE
1.0%
of all FENOFIBRATE reports
25
Deaths
57
Hospitalizations

How Dangerous Is Multiple organ dysfunction syndrome From FENOFIBRATE?

Of the 59 reports, 25 (42.4%) resulted in death, 57 (96.6%) required hospitalization, and 29 (49.2%) were considered life-threatening.

Is Multiple organ dysfunction syndrome Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for FENOFIBRATE. However, 59 reports have been filed with the FAERS database.

What Other Side Effects Does FENOFIBRATE Cause?

Myalgia (411) Dyspnoea (373) Fatigue (365) Asthenia (356) Dizziness (356) Fall (354) Drug ineffective (326) Pruritus (325) Nausea (311) Diarrhoea (310)

What Other Drugs Cause Multiple organ dysfunction syndrome?

TACROLIMUS (1,847) CYCLOPHOSPHAMIDE (1,597) MYCOPHENOLATE MOFETIL (1,566) PREDNISONE (1,525) DEXAMETHASONE (1,355) METHOTREXATE (1,317) METHYLPREDNISOLONE (1,278) RITUXIMAB (1,188) PREDNISOLONE (1,154) CYCLOSPORINE (933)

Which FENOFIBRATE Alternatives Have Lower Multiple organ dysfunction syndrome Risk?

FENOFIBRATE vs FENOFIBRIC ACID FENOFIBRATE vs FENOTEROL FENOFIBRATE vs FENOTEROL HYDROBROMIDE FENOFIBRATE vs FENOTEROL HYDROBROMIDE\IPRATROPIUM FENOFIBRATE vs FENTANYL

Related Pages

FENOFIBRATE Full Profile All Multiple organ dysfunction syndrome Reports All Drugs Causing Multiple organ dysfunction syndrome FENOFIBRATE Demographics